​

Biohaven (BHVN) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

BHVN Stock Forecast

Biohaven (BHVN) stock forecast, based on 25 Wall Street analysts, predicts a 12-month average price target of $22.50, with a high of $42.00 and a low of $11.00. This represents a 103.99% increase from the last price of $11.03.

$10 $19 $28 $37 $46 $55 High: $42 Avg: $22.5 Low: $11 Last Closed Price: $11.03

BHVN Stock Rating

Biohaven stock's rating consensus is Buy, based on 25 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (68.00%), 8 Hold (32.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 25 8 17 0 Strong Sell Sell Hold Buy Strong Buy

BHVN Price Target Upside V Benchmarks

TypeNameUpside
StockBiohaven103.99%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts346
Avg Price Target$16.00$22.50$34.50
Last Closing Price$11.03$11.03$11.03
Upside/Downside45.06%103.99%212.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 253105--18
Nov, 254131--18
Oct, 254131--18
Sep, 254111--16
Aug, 254111--16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 03, 2025H.C. Wainwright$11.00$8.8324.58%-0.27%
Nov 26, 2025UBS$11.00$9.2419.05%-0.27%
Nov 18, 2025Morgan Stanley$26.00$9.45175.13%135.72%
Nov 05, 2025Brian SkorneyRobert W. Baird$42.00$13.95201.08%280.78%
Mar 20, 2025Deutsche Bank$60.00$28.18112.92%443.97%
Mar 04, 2025Bernstein$57.00$31.3781.70%416.77%
Dec 04, 2024Leonid TimashevRBC Capital$61.00$46.5830.96%453.04%
Oct 15, 2024Jason GerberryBank of America Securities$65.00$52.7723.18%489.30%
Sep 24, 2024Marc GoodmanLeerink Partners$60.00$44.2235.69%443.97%
Sep 24, 2024Douglas TsaoH.C. Wainwright$59.00$45.9428.43%434.90%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 03, 2025H.C. WainwrightBuyNeutraldowngrade
Nov 26, 2025UBSBuyNeutraldowngrade
Nov 11, 2025William BlairMarket PerformMarket Performhold
Nov 05, 2025William BlairOutperformMarket Performdowngrade
Nov 05, 2025Cowen & Co.BuyBuyhold
Nov 05, 2025William BlairOutperformOutperformhold
Nov 05, 2025Morgan StanleyOverweightOverweighthold
Nov 05, 2025Raymond JamesStrong BuyStrong Buyhold
Sep 17, 2025CitigroupBuyinitialise
Sep 02, 2025Raymond JamesStrong Buyinitialise

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.97$-12.75$-5.73$-9.28----
Avg Forecast$-7.31$-9.79$-5.22$-9.01$-6.36$-5.57$-4.11$-1.78
High Forecast$-5.85$-0.41$-5.00$-8.11$-5.49$-3.72$-1.29$-0.08
Low Forecast$-8.77$-22.52$-5.45$-9.94$-7.27$-7.15$-6.30$-4.10
Surprise %-18.33%30.23%9.77%3.00%----

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$462.51M-------
Avg Forecast$426.10M$820.28M-$7.69M$18.54M$154.46M$501.96M$898.51M
High Forecast$511.32M$984.33M-$15.39M$37.10M$309.07M$510.22M$1.80B
Low Forecast$340.88M$656.22M-$2.03M$4.88M$40.67M$493.70M$236.60M
Surprise %8.54%-------

Net Income Forecast

$-850M $-680M $-510M $-340M $-170M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-213.80M$-570.28M$-408.17M$-846.42M----
Avg Forecast$-596.80M$-620.81M$-408.17M$-642.41M$-454.23M$-386.92M$-270.35M$-126.97M
High Forecast$-477.44M$-496.65M$-326.53M$-577.16M$-391.03M$-265.06M$-91.93M$-5.37M
Low Forecast$-716.16M$-744.97M$-489.80M$-707.67M$-517.43M$-508.79M$-448.78M$-292.19M
Surprise %-64.18%-8.14%-31.76%----

BHVN Forecast FAQ

Is Biohaven stock a buy?

Biohaven stock has a consensus rating of Buy, based on 25 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 8 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Biohaven is a favorable investment for most analysts.

What is Biohaven's price target?

Biohaven's price target, set by 25 Wall Street analysts, averages $22.5 over the next 12 months. The price target range spans from $11 at the low end to $42 at the high end, suggesting a potential 103.99% change from the previous closing price of $11.03.

How does Biohaven stock forecast compare to its benchmarks?

Biohaven's stock forecast shows a 103.99% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Biohaven over the past three months?

  • December 2025: 16.67% Strong Buy, 55.56% Buy, 27.78% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 22.22% Strong Buy, 72.22% Buy, 5.56% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 22.22% Strong Buy, 72.22% Buy, 5.56% Hold, 0% Sell, 0% Strong Sell.

What is Biohaven’s EPS forecast?

Biohaven's average annual EPS forecast for its fiscal year ending in December 2025 is $-6.36, marking a -31.47% decrease from the reported $-9.28 in 2024. Estimates for the following years are $-5.57 in 2026, $-4.11 in 2027, and $-1.78 in 2028.

What is Biohaven’s revenue forecast?

Biohaven's average annual revenue forecast for its fiscal year ending in December 2025 is $18.54M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $154.46M, followed by $501.96M for 2027, and $898.51M for 2028.

What is Biohaven’s net income forecast?

Biohaven's net income forecast for the fiscal year ending in December 2025 stands at $-454M, representing a -46.34% decrease from the reported $-846M in 2024. Projections indicate $-387M in 2026, $-270M in 2027, and $-127M in 2028.